Free · 13,587 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Other

Photobiomodulation in animal models of ophthalmic disease: protocol for systematic review and meta-analysis of morphological, visual function, and inflammatory outcomes

Findings will contribute to future trial designs and support the development of standardized protocols for PBM applications in ophthalmology.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

This protocol describes a planned systematic review and meta-analysis of animal studies testing photobiomodulation in four eye conditions: age-related macular degeneration, diabetic retinopathy, glaucoma and corneal injury. The authors plan to group outcomes into morphological, visual functional and inflammatory domains and to assess study quality. No results are reported, so the protocol does not show whether the treatment is effective.

Who or what was studied
Animal models of age-related macular degeneration, diabetic retinopathy, glaucoma and corneal injury
Limits stated in the abstract
This is a protocol only, with no results, and it covers animal and preclinical studies whose findings may not apply to humans.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Background

Despite accumulating preclinical evidence supporting the therapeutic efficacy of photobiomodulation (PBM) in ophthalmic disease models, the systematic evaluation and quantitative synthesis of these findings remain underexplored. This protocol aims to comprehensively synthesize existing studies by categorizing outcome measures into morphological, visual, and inflammatory domains according to ophthalmic pathology. The primary objective of this study is to evaluate the therapeutic efficacy of PBM for ophthalmic diseases and to consolidate the current body of preclinical evidence.

Methods

This study will be conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocols (PRISMA-P) guidelines. We will include controlled preclinical studies using animal models of four predefined ophthalmic conditions: age-related macular degeneration (AMD), diabetic retinopathy (DR), glaucoma, and corneal injury. A systematic search will be conducted across relevant electronic databases without restrictions on publication date. Outcomes will be categorized into three domains, morphological, visual functional, and inflammatory, to evaluate the efficacy of PBM in ophthalmic diseases. Two independent reviewers will perform study selection, data extraction, and risk of bias assessment using the SYRCLE tool. Where appropriate, meta-analyses will be conducted using random-effects models, with heterogeneity assessed using I2 statistics. Subgroup and sensitivity analyses will be performed to explore sources of variability.

Discussion

This systematic review aims to integrate and assess the quality of current evidence regarding PBM's efficacy across morphological, visual functional, and inflammatory outcomes. Findings will contribute to future trial designs and support the development of standardized protocols for PBM applications in ophthalmology. SYSTEMATIC REVIEW

Registration

https://www.crd.york.ac.uk/PROSPERO/view/CRD420251054002, PROSPERO CRD420251054002.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Systematic review, Meta-analysis, Age-related macular degeneration, Heterogeneity, Risk of bias. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies